UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Governors Lane LP

Governors Lane LP cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.9% during the 4th quarter, Holdings Channel reports. The firm owned 22,600 shares of the healthcare conglomerate’s stock after selling 6,700 shares during the period. UnitedHealth Group comprises 0.9% of Governors Lane LP’s investment portfolio, making the stock its 24th largest position. Governors Lane LP’s holdings in UnitedHealth Group were worth $11,432,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Sugarloaf Wealth Management LLC lifted its stake in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Signal Advisors Wealth LLC boosted its stake in shares of UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Waycross Partners LLC lifted its holdings in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after purchasing an additional 658 shares during the last quarter. Czech National Bank increased its stake in UnitedHealth Group by 6.1% in the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock worth $100,937,000 after purchasing an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC lifted its stake in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after buying an additional 4,022 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $380.72 on Friday. The company has a market cap of $346.54 billion, a P/E ratio of 24.56, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $378.54 and a 1 year high of $630.73. The company has a fifty day simple moving average of $488.01 and a 200 day simple moving average of $522.60.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the firm posted $6.91 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 2.21%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is presently 35.18%.

Analyst Ratings Changes

A number of research firms recently commented on UNH. KeyCorp decreased their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Oppenheimer lowered their price target on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday, April 21st. Raymond James reaffirmed a “strong-buy” rating and set a $540.00 target price (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Truist Financial decreased their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a report on Monday, April 21st. Finally, Robert W. Baird cut their target price on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating for the company in a research report on Tuesday, April 29th. Four research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.